View the most important information about the COVID-19 vaccines complied by LUNGevity. #WebPage #CollaborativePartner #LUNGevity #Patient #PatientAdvocate #2021
LUNGevity has developed a comprehensive series of materials for lung cancer patients and their caregivers, focused on understanding how lung cancer develops, how it can be diagnosed, and treatment options. Whether you or someone you care about has been diagnosed with lung cancer, or is concerned...
2 attachments
LUNGevity's Patient Education Series offers several comprehensive booklets and brochures written and illustrated clearly to help patients understand their diagnosis and treatment options as well as the support services available through LUNGevity. These materials will help you learn about lung...
In this blog post, Dr. Upal Basu Roy, Senior Director of Research at LUNGevity, provides an update on the predictors of immunotherapy toxicities. Click here to read this informative blog post. #Biomarkers #NonSmallCellLungCancer #WebPage #CollaborativePartner #SideEffects ...
If you’ve been diagnosed with non-small cell lung cancer, you should ask your doctor about comprehensive biomarker testing. For some kinds of lung cancer, comprehensive biomarker testing may provide information on whether there are changes in the cancer cells that can be treated with targeted...
Biomarker tests may provide information about changes, or mutations, in the cells that became cancer and whether a treatment is available that targets this change. For some kinds of lung cancer, biomarker testing may be performed to provide information on whether there are changes in the cancer...
LUNGevity sat down with Patrick Forde, MD (MB, BCH), Associate Professor of Oncology at the Johns Hopkins School of Medicine, to discuss the results of the PACIFIC trial and what it means for the lung cancer survivor community. Dr. Forde is an expert on immunotherapies for lung cancer and has...
LUNGevity sat down with Zofia (Zosia) Piotrowska, MD, from Massachusetts General Hospital (MGH)/ Harvard Medical School to discuss the role of comprehensive biomarker testing (CBT) for treatment decision making for patients with advanced-stage NSCLC. Dr. Piotrowska is a thoracic medical...
Small cell lung cancer (SCLC) accounts for about 15% of all lung cancers. In addition to existing treatment approaches, several promising new treatment approaches are being developed. This website can help you: Learn about small cell lung cancer Understand the treatment options available...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us